TCI Wealth Advisors, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$18,217
-27.4%
477
+8.2%
0.00%
-33.3%
Q4 2022$25,093
+47.6%
441
+0.2%
0.00%0.0%
Q3 2022$17,000
-10.5%
440
+1.4%
0.00%0.0%
Q2 2022$19,000
+11.8%
4340.0%0.00%0.0%
Q1 2022$17,0000.0%4340.0%0.00%0.0%
Q4 2021$17,000
+70.0%
434
+83.1%
0.00%
+50.0%
Q3 2021$10,000
+150.0%
237
+189.0%
0.00%
+100.0%
Q2 2021$4,000
-33.3%
82
-44.6%
0.00%
-66.7%
Q1 2021$6,000148
+7300.0%
0.00%
Q4 2020$0
-100.0%
2
-99.6%
0.00%
-100.0%
Q1 2015$7,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders